REC608-Recombinant HSV Vaccine

HSV is a key cause of genital herpes. We are developing a recombinant HSV vaccine (i.e., REC608) with our technology platform, taking into account a multi-antigen combination scheme in the antigen design to fully utilize the enhanced immunity effect of the adjuvant, as well as the influence of mucosal immunity, The project is currently in the preclinical research stage.